BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
T cell receptor signaling pathway
,
Arthritis
,
Heart
,
Laryngoscope
,
Lipitor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
subunit protein
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Understanding of protomers/deprotomers by combining mass spectrometry and computation.
Protomers of the green and cyan fluorescent protein chromophores investigated using action spectrosc…
Advances in protein subunit vaccines against tuberculosis.
A mathematical model of protein subunits COVID-19 vaccines.
Quantitative analysis of NMDA receptor subunits proteins in mouse brain.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Booster Study of COVID-19 Protein Subunit Recombinant Vaccine
Heterologous Booster Study of COVID-19 Protein Subunit Recombinant Vaccine in Children 12-17 Years o…
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine in Healthy Children
Safety and Immunogenicity of SARS-CoV-2 Protein Subunit Recombinant Vaccine
Immuno-bridging Study of COVID-19 Protein Subunit Recombinant Vaccine
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ